Automated four-dimensional long term imaging enables single cell tracking within organotypic brain slices to study neurodevelopment and degeneration.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
2019
Historique:
received: 28 08 2018
accepted: 18 03 2019
entrez: 10 5 2019
pubmed: 10 5 2019
medline: 10 5 2019
Statut: epublish

Résumé

Current approaches for dynamic profiling of single cells rely on dissociated cultures, which lack important biological features existing in tissues. Organotypic slice cultures preserve aspects of structural and synaptic organisation within the brain and are amenable to microscopy, but established techniques are not well adapted for high throughput or longitudinal single cell analysis. Here we developed a custom-built, automated confocal imaging platform, with improved organotypic slice culture and maintenance. The approach enables fully automated image acquisition and four-dimensional tracking of morphological changes within individual cells in organotypic cultures from rodent and human primary tissues for at least 3 weeks. To validate this system, we analysed neurons expressing a disease-associated version of huntingtin (HTT586Q138-EGFP), and observed that they displayed hallmarks of Huntington's disease and died sooner than controls. By facilitating longitudinal single-cell analyses of neuronal physiology, our system bridges scales necessary to attain statistical power to detect developmental and disease phenotypes.

Identifiants

pubmed: 31069265
doi: 10.1038/s42003-019-0411-9
pii: 411
pmc: PMC6494885
doi:

Substances chimiques

HTT protein, human 0
Huntingtin Protein 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Pagination

155

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS039074
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH115747
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS083390
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG056151
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG054407
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG058476
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG058447
Pays : United States

Déclaration de conflit d'intérêts

S.M.F. is the inventor of Robotic Microscopy Systems, U.S. Patent 7,139,415 and Automated Robotic Microscopy Systems, U.S. Patent Application 14/737,325, both assigned to The J. David Gladstone Institutes. The remaining authors declare no competing interests.

Références

CNS Neurosci Ther. 2012 Apr;18(4):285-94
pubmed: 22070283
Trends Mol Med. 2013 Oct;19(10):604-13
pubmed: 24007818
Neuron. 2007 Sep 6;55(5):697-711
pubmed: 17785178
Development. 2013 Jul;140(13):2823-7
pubmed: 23720045
J Neurol Sci. 2017 May 15;376:242-254
pubmed: 28431620
Cell. 2011 Jul 8;146(1):18-36
pubmed: 21729779
Sci Rep. 2015 Sep 29;5:14624
pubmed: 26416689
Cell. 2016 May 5;165(4):921-35
pubmed: 27114033
Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):14408-14413
pubmed: 27911847
J Neurosci. 2010 Jan 13;30(2):639-49
pubmed: 20071528
Brain Res Dev Brain Res. 1997 Jan 2;98(1):21-9
pubmed: 9027401
Proc Natl Acad Sci U S A. 2015 Jun 23;112(25):7821-6
pubmed: 26056265
BMC Med Res Methodol. 2010 Mar 16;10:20
pubmed: 20233435
Commun Integr Biol. 2009 Jul;2(4):318-20
pubmed: 19721877
Nat Protoc. 2006;1(3):1223-6
pubmed: 17406405
Front Mol Neurosci. 2017 Feb 28;10:50
pubmed: 28293168
Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):1165-1170
pubmed: 28028237
Neuron. 2015 Apr 8;86(1):160-74
pubmed: 25856492
Neurobiol Dis. 2011 Jul;43(1):248-56
pubmed: 21458569
Front Aging Neurosci. 2017 Mar 24;9:71
pubmed: 28392767
Adv Pharmacol. 2017;79:141-171
pubmed: 28528667
J Neurosci Methods. 2006 Oct 15;157(1):1-9
pubmed: 16704878
Nature. 2013 Sep 5;501(7465):45-51
pubmed: 24005412
Neuron. 2014 Mar 5;81(5):1009-1023
pubmed: 24607225
Nat Methods. 2018 Jan 3;15(1):24-26
pubmed: 29298292
Methods Enzymol. 2012;506:331-60
pubmed: 22341232
J Neurosci Methods. 1981 Dec;4(4):329-42
pubmed: 7033675
J Biol Chem. 2011 Jun 10;286(23):20710-26
pubmed: 21489994
Nature. 2010 Mar 25;464(7288):554-561
pubmed: 20154730
Nature. 2004 Oct 14;431(7010):805-10
pubmed: 15483602
Nat Neurosci. 2014 Aug;17(8):1064-72
pubmed: 25017010
Mol Neurodegener. 2016 Jun 10;11(1):44
pubmed: 27287430
J Neurocytol. 2000 Sep;29(9):679-702
pubmed: 11353291
J Neurosci Methods. 1991 Apr;37(2):173-82
pubmed: 1715499
J Neurosci. 2010 Aug 4;30(31):10541-50
pubmed: 20685997
Nat Chem Biol. 2014 Aug;10(8):677-85
pubmed: 24974230
Sci Rep. 2016 May 12;6:25626
pubmed: 27172999
Nature. 2014 Nov 13;515(7526):264-8
pubmed: 25391964
PLoS One. 2012;7(9):e45017
pubmed: 22984603
J Neurosci. 2016 Sep 28;36(39):9977-89
pubmed: 27683896
Cell Logist. 2012 Oct 1;2(4):176-188
pubmed: 23538475
Brain. 2012 Sep;135(Pt 9):2750-65
pubmed: 22915735
Biometrics. 2016 Sep;72(3):936-44
pubmed: 26821783
Science. 2017 Dec 8;358(6368):1318-1323
pubmed: 29217575
Nature. 2017 May 4;545(7652):54-59
pubmed: 28445465
Methods Mol Biol. 2004;277:161-71
pubmed: 15201455
Neurosci Res. 2010 Dec;68(4):315-21
pubmed: 20727917
Curr Protoc Mol Biol. 2010 Oct;Chapter 14:Unit14.20
pubmed: 20890901
Nat Commun. 2013;4:1665
pubmed: 23575669
J Neurosci. 2014 Jan 8;34(2):418-33
pubmed: 24403142
Nat Neurosci. 2013 Nov;16(11):1576-87
pubmed: 24097039
J Clin Invest. 2016 Sep 1;126(9):3585-97
pubmed: 27525439
Lancet. 2007 Jan 20;369(9557):218-28
pubmed: 17240289
Ann Neurol. 2011 Oct;70(4):532-40
pubmed: 22028219
Nat Protoc. 2006;1(2):977-81
pubmed: 17406333
Front Neurosci. 2017 Nov 28;11:647
pubmed: 29234268
J Neurosci Methods. 2018 Sep 1;307:203-209
pubmed: 29859877
PLoS One. 2013 Jul 08;8(7):e68357
pubmed: 23861892
FEBS J. 2018 Jan;285(2):203-219
pubmed: 28613457
Trends Neurosci. 1997 Oct;20(10):471-7
pubmed: 9347615
Neuron. 2016 Sep 21;91(6):1219-1227
pubmed: 27657449
Proc Natl Acad Sci U S A. 2006 Jul 5;103(27):10461-10466
pubmed: 16793926
Nature. 2000 Jul 13;406(6792):195-9
pubmed: 10910361
J Neurol Neurosurg Psychiatry. 1993 May;56(5):487-91
pubmed: 8505640
J Neurosci Methods. 2001 Nov 15;112(1):57-64
pubmed: 11640958

Auteurs

Jeremy W Linsley (JW)

Gladstone Center for Systems and Therapeutics, San Francisco, CA 94158 USA.

Atmiyata Tripathi (A)

Gladstone Center for Systems and Therapeutics, San Francisco, CA 94158 USA.

Irina Epstein (I)

Gladstone Center for Systems and Therapeutics, San Francisco, CA 94158 USA.

Galina Schmunk (G)

2Department of Anatomy, University of California, San Francisco, CA 94158 USA.

Elliot Mount (E)

Gladstone Center for Systems and Therapeutics, San Francisco, CA 94158 USA.

Matthew Campioni (M)

Gladstone Center for Systems and Therapeutics, San Francisco, CA 94158 USA.

Viral Oza (V)

Gladstone Center for Systems and Therapeutics, San Francisco, CA 94158 USA.

Mariya Barch (M)

Gladstone Center for Systems and Therapeutics, San Francisco, CA 94158 USA.

Ashkan Javaherian (A)

Gladstone Center for Systems and Therapeutics, San Francisco, CA 94158 USA.

Tomasz J Nowakowski (TJ)

2Department of Anatomy, University of California, San Francisco, CA 94158 USA.

Siddharth Samsi (S)

3Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Luxembourg, L-4367 Luxembourg.
9Present Address: MIT Lincoln Laboratory, Lexington, MA 02421 USA.

Steven Finkbeiner (S)

Gladstone Center for Systems and Therapeutics, San Francisco, CA 94158 USA.
4Neuroscience Graduate Program, University of California, San Francisco, CA 94158 USA.
5Biomedical Sciences and Neuroscience Graduate Program, University of California, San Francisco, CA 94143 USA.
6Taube/Koret Center for Neurodegenerative Disease, Gladstone Institutes, San Francisco, CA 94158 USA.
7Department of Neurology, University of California, San Francisco, CA 94158 USA.
8Department of Physiology, University of California, San Francisco, CA 94158 USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH